Physician profile
John Kung
NPI 1760483390
$2,017.63
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $157 · 2020: $148 · 2021: $34.60 · 2022: $1,318 · 2023: $261 · 2024: $98.83.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $360.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $359.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medwest Associates | $1,237.23 | 2022 | |
| Endo Pharmaceuticals INC. | $199.49 | 2019-2024 | Xiaflex |
| Stryker Corporation | $109.10 | 2023 | T2, Gamma |
| Boston Scientific Corporation | $94.64 | 2021-2023 | Superion Indirect Decompression System |
| Depuy Synthes Sales INC. | $69.61 | 2019-2023 | Monovisc |
| Orthofix Medical, INC. | $48.02 | 2020-2022 | |
| Pacira Pharmaceuticals Incorporated | $47.32 | 2024 | Exparel, Iovera, Zilretta |
| Acumed LLC | $42.41 | 2023 | Acumed, Innate Implant |
| Amgen INC. | $28.41 | 2024 | Krystexxa |
| Nevro Corp. | $27.30 | 2020 | |
| Smith+Nephew, INC. | $24.92 | 2022 | |
| Horizon Therapeutics Plc | $20.38 | 2019 | |
| Integra Lifesciences Corporation | $16.48 | 2020 | |
| Zyla Life Sciences, INC. | $15.30 | 2020 | |
| Axogen | $13.02 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Electronic Waveform Lab, INC. | $12.93 | 2019 | |
| Trice Medical, INC. | $11.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Kung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.